TABLE 2.
Derivative | Ki (nM)a | EC50(nM)a | Efficacymaxc |
---|---|---|---|
Riboside | |||
CI-IB-MECA | 2.8 | 1.9 | 100% |
(N)-Methanocarba | |||
MRS 1743 | 9.2 | 0.70b | 13%b |
MRS 1760 | 1.9 | 0.67b | 3%b |
MRS 1898 | 1.9 | 2.1 | 100% |
Ki values refer to inhibition of the binding of [125I]I-AB-MECA and EC50 refers to inhibition of cyclic AMP production, unless noted.
In a functional assay based on guanine nucleotide binding [Jacobson et al., 2000], the efficacy of MRS 1743 and MRS 1760 was determined to be 45% and 22%, respectively.
cAMP effects.